The MYC family member c-MYC and MYCN are the most frequently deregulated oncogenes in human cancer and promote tumor progression through multiple levels of mechanisms in particular reprogrammed metabolism (Yoshida, 2020). This evidence concerns the gene MYC and neoplasm.